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In women, high levels of natural progesterone have been associated with
detrimental cognitive effects via the “maternal amnesia” phenomenon as well
as in controlled experiments. In aged ovariectomized (Ovx) rats, progesterone
has been shown to impair cognition and impact the GABAergic system in
cognitive brain regions. Here, we tested whether the GABAergic system is a
mechanism of progesterone’s detrimental cognitive effects in the Ovx rat by
attempting to reverse progesterone-induced impairments via concomitant treatment
with the GABAA antagonist, bicuculline. Thirteen month old rats received Ovx
plus daily vehicle, progesterone, bicuculline, or progesterone+bicuculline injections
beginning 2 weeks prior to testing. The water radial-arm maze was used to
evaluate spatial working and reference memory. During learning, rats administered
progesterone made more working memory errors than those administered vehicle,
and this impairment was reversed by the addition of bicuculline. The progesterone
impairment was transient and all animals performed similarly by the end of
regular testing. On the last day of testing, a 6 hour delay was administered
to evaluate memory retention. Progesterone-treated rats were the only group to
increase working memory errors with the delay relative to baseline performance;
again, the addition of bicuculline prevented the progesterone-induced impairment.
The vehicle, bicuculline, and progesterone+bicuculline groups were not impaired
by the delay. The current rodent findings corroborate prior research reporting
progesterone-induced detriments on cognition in women and in the aging Ovx
rat. Moreover, the data suggest that the progesterone-induced cognitive impairment
is, in part, related to the GABAergic system. Given that progesterone is included
in numerous clinically-prescribed hormone therapies and contraceptives (e.g.,
micronized), and as synthetic analogs, further research is warranted to better
understand the parameters and mechanism(s) of progesterone-induced cognitive
impairments.
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Introduction
Within their lifetime, women will have to make the decision of
whether to take exogenous hormones, either for contraception or
for hormone therapy (HT) associated with menopause. Women
that have a uterus must include a progestogen in their HT
regimen to protect against endometrial hyperplasia (Smith et al.,
1975). The most commonly prescribed progestin component
of HT, and the sole hormone component of the contraceptive
Depo Provera, medroxyprogesterone acetate (MPA), has been
associated with memory impairments in rodent models across
the adult lifespan (Braden et al., 2010, 2011; Lowry et al., 2010;
Okojie and Oyekunle, 2014) and adverse in vitro cellular effects
(Nilsen and Brinton, 2002b; Nilsen et al., 2006). There is evidence
in postmenopausal women that combination HT treatment
including MPA increases the risk of dementia (Shumaker
et al., 2003; Coker et al., 2010). In women, like MPA, natural
progesterone is associated with detrimental effects on cognition
in both the phenomenon of ‘‘maternal amnesia’’ (Brett and
Baxendale, 2001) and in controlled studies of healthy women
receiving oral progesterone (Freeman et al., 1992; van Wingen
et al., 2007). Progesterone can impair memory in young and
aged rodent models (Bimonte-Nelson et al., 2004b; Braden et al.,
2010; Sun et al., 2010) and reverse the beneficial effects of
17β-estradiol in vivo (Bimonte-Nelson et al., 2006; Harburger
et al., 2007; but see Gibbs, 2000; Markham et al., 2002) and in
vitro (Nilsen and Brinton, 2002a; Aguirre and Baudry, 2009).
Further, administration of allopregnanolone, a progesterone
metabolite, has been shown to impair cognition in healthy
women (Kask et al., 2008) and young rats (Frye and Sturgis,
1995; Ladurelle et al., 2000; Johansson et al., 2002; Rabinowitz
et al., 2014). These findings are particularly salient since the
use of progesterone (specifically, natural progesterone in its
micronized form to be orally bioavailable) as the progestogen
component of HT has become an option for women in the
United States as recently as 1999 (Langer, 1999) and is a
promising new candidate to replace MPA (Sturdee et al.,
2011; The Writing Group for the PEPI Trial, 1995; Langer,
1999).
Preclinical studies indicate that a potential mechanism
for progesterone-induced memory impairments includes the
GABAergic system. Several metabolites of progesterone have
a high affinity for the GABAA receptor wherein they can
act as positive allosteric modulators (Paul and Purdy, 1992).
Further, administration of progesterone decreases glutamic acid
decarboxylase (GAD, the synthesizing enzyme and the rate
limiting step of GABA production), protein levels (Braden
et al., 2010) and mRNA activity (Wallis and Luttge, 1980),
and can alter mRNA expression of subunits of the GABAA
receptor, in the hippocampus of ovariectomized (Ovx) rats
(Weiland and Orchinik, 1995; Pazol et al., 2009). Further, in
young Ovx mice, treatment with a GABAA receptor antagonist
attenuates the impairing effect of progesterone on an emotional
learning task (Farr et al., 1995). It remains to be determined,
however, whether the GABAergic system is a mechanism of
progesterone’s effects on cognition during aging in the Ovx
rat. We hypothesize that progesterone administration impairs
cognition in the Ovx middle-aged or aged rat through an
increase in GABA-mediated inhibition in the hippocampus,
likely via its metabolites (Lan and Gee, 1994). Subsequently, an
increase in GABA-mediated inhibition could impair memory
by inhibiting the induction phase of long-term potentiation
(LTP; Izquierdo et al., 1993). We propose to address the
question of whether progesterone’s effects on memory are,
in part, due to GABAA modulation by administering the
GABAA receptor antagonist, bicuculline, to progesterone-treated
middle-aged surgically menopausal animals. We predict that
bicuculline will prevent progesterone’s negative effects on
cognition. Investigating the GABAergic system’s relationship
to progesterone’s cognitive effects in an animal model is a
critical step in answering questions regarding the putative
mechanisms by which natural progesterone impairs cognition.
With this knowledge, we can move forward in the field
of behavioral endocrinology studying progestogens that do
not share these pharmacological characteristics, and are thus
potentially safer alternatives to be used clinically for brain health
and function.
Materials and Methods
Subjects
The subjects used in this study were 37, 13-month old Fischer-
344 virgin female rats. Animals were born and reared within
the aging colony at the National Institute on Aging at Harlan
Laboratories (Indianapolis, IN, USA). Rats had access to food
and water ad-lib, were maintained on a 12 h light/dark cycle, and
were acclimated for several weeks before surgery was initiated at
the Arizona State University animal facility. All procedures used
in this study were approved by the local IACUC committee, and
they adhered to NIH standards.
Hormone Treatment and Ovariectomy
Rats were randomly assigned to one of four treatment groups:
Ovx+Vehicle, Ovx+Progesterone (Ovx+Prog), Ovx+Bicuculline
(Ovx+Bic), or Ovx+Prog+Bic. At the age of 13 months, all
rats received isofluorane inhalation anesthesia, underwent
dorsolateral incisions made bilaterally in the skin and
peritoneum, and the ovaries and the tips of uterine horns were
ligatured and removed. Next, muscle and skin were sutured.
Beginning two days after surgery all drugs were administered
via two daily subcutaneous injections in the scruff of the neck.
For the first injection given daily, animals received either a
control vehicle solution [0.4 mL sesame oil + 0.02 mL dimethyl
sulfoxide (DMSO), both chemicals were from Sigma-Aldrich,
St. Louis, MO, USA] or progesterone (0.7 mg, Sigma-Aldrich
St. Louis, MO, USA; dissolved in 0.4 mL sesame oil + 0.02
mL DMSO). The progesterone dose was chosen as the daily
equivalent of what animals received via osmotic subcutaneous
pumps in Braden et al. (2010) whereby progesterone impaired
memory in aged Ovx rats. For the second injection given daily,
animals received either a control vehicle solution (sesame oil
+ 10% DMSO) or bicuculline (3.5 mg/kg; dissolved in sesame
oil + 10% DMSO). Importantly, we determined that this dose
of bicuculline was subthreshold for clinically visible signs of
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seizures in a different cohort of animals prior to initiation of
the current study, corresponding with findings shown by other
investigators (Brioni and McGaugh, 1988). Injections were
continued through all behavior testing (approx. 30 m prior to
testing) until sacrifice occurred.
Vaginal Smears and Uterine Weights
Vaginal smears were evaluated 12 and 13 days after Ovx (and
therefore after hormone and/or drug administration began).
They were classified as proestrus, estrous, metestrus or diestrous
based on prior protocols (Goldman et al., 2007; Acosta et al.,
2009). At the time of sacrifice, the uterus of each subject was
extracted, visible fat was trimmed, and the remaining tissue was
immediately weighed (wet weight), in order to assess the impact
of the hormone and drug on uterine tissues (Braden et al., 2010,
2011).
Water Radial-Arm Maze
Thirteen days after initiation of treatment subjects began maze
testing, with timing similar to previous studies in our laboratory
(Talboom et al., 2010). Subjects were tested on the water radial-
arm maze (WRAM) for 15 days to test spatial working and
reference memory, including performance as working memory
load increases, as described in prior publications (Bimonte and
Denenberg, 2000; Bimonte et al., 2000, 2002). The maze had
escape platforms hidden under the surface of the water at
the ends of four of the eight radiating arms. A subject was
assigned different platform locations which remained fixed for
the duration of testing. Each rat was released from the start arm
and had 3 m to find a hidden platform. Once a platform was
located, the animal remained on it for 15 s, and was returned
to its warmed cage for a 30 s inter-trial interval (ITI) until its
next trial began. The just-chosen platform was then removed
from the maze during the ITI. Next, the subject was again
placed into the start alley and was allowed to locate another
platform. For each rat, a session within a day was composed
of four trials, with the number of platformed arms reduced
by one for each subsequent trial. Thus, working memory was
increasingly taxed as the trials progressed within a day, allowing
us to test the ability to handle an increasing working memory
load. Each subject was given one session a day for 14 consecutive
days. On Day 15, a 6 h delay was administered between Trials
2 and 3, as done previously in our laboratory for middle-age
animals on other water-escape tasks (Engler-Chiurazzi et al.,
2011, 2012).
Quantification and blocking of errors were based on prior
studies (Hyde et al., 1998, 2000; Bimonte and Denenberg, 2000;
Bimonte et al., 2000, 2002). When the tip of a rat’s snout reached
a mark demarcated on the outside of the arm (11 cm into the
arm), an arm entry, or error, was counted. Errors were computed
as done previously in WRAM studies (Bimonte et al., 2000,
2002; Hyde et al., 2000), and were quantified into working and
reference memory errors (Jarrard et al., 1984). Working Memory
Correct (WMC) errors were defined as the number of first and
repeat entries into an arm from which a platform had been
removed during that daily session. For WMC errors, Trial 1 was
not included in analyses because a platform had not yet been
removed. Reference Memory (RM) errors were defined as the
number of first entries into an arm that never had a platform,
and Working Memory Incorrect (WMI) errors were repeat
entries into a RM arm. Our traditional protocol for evaluating
treatment effects on the WRAM includes testing for 11–12 days
and blocking errors into two blocks of 5–6 days (Bimonte and
Denenberg, 1999; Bimonte et al., 2000; Braden et al., 2011). In
the current study, however, animals required 14 days of regular
testing to reach asymptotic performance, most likely due to the
increased stress of multiple subcutaneous injections 30 m before
test. Thus, to most thoroughly evaluate performance as learning
progressed, errors were combined into three blocks (Block 1 =
days 1–4, Block 2 = days 5–9, Block 3 = days 10–14).
Visible Platform Maze
To confirm that all rats could execute the procedural task
components of a water-escape task without difficulty, every
animal was tested on a visible platform water-escape maze, as
done previously (Braden et al., 2010, 2011). A rectangular tub
(39 × 23 in) was filled with clear water and had a visible black
platform (10 cm wide) elevated above the surface of the water.
Extramaze cues on the walls were covered with opaque curtains.
Rats were dropped off at the samemaze location across trials, and
the location of the platform for each trial varied in space semi-
randomly (e.g., the platform was moved across trials). Subjects
were required to locate the protruding platform, and were given
6 trials in 1 day.Maze performance was evaluated by latency (s) to
the platform. Animals were sacrificed 3 days after visible platform
maze testing.
Statistical Analyses
Data were analyzed separately for each maze. To evaluate
learning and potentially complex higher order Treatment group
interactions with Days and/or Trials, an omnibus repeated
measures ANOVA including all groups, with Treatment as the
between variable, and blocks of Days and/or Trials as the within
variable/s, was used. For uterine weights, Treatment effects were
assessed via ANOVA. When ANOVA yielded a significant effect
of Treatment, two group comparisons using t-tests were used to
investigate group differences. For all statistical analyses, alpha
was set as two-tailed and at 0.05, except for when assessing
WRAM working memory (WMC and WMI) error differences
on trial 4 alone, the trial with the highest working memory load,
between Ovx+Prog and Ovx+Vehicle. For these assessments the
test was one-tailed, as they were a replication from Bimonte-
Nelson et al. (2004b) and Braden et al. (2010).
Results
Water Radial-Arm Maze
For the omnibus ANOVA, across all testing days (Days 1–14) and
including all treatment groups, there was a main effect of Day
for each error type (WMC: F(13,429) = 5.828; p < 0.0001; WMI:
F(13,429) = 11.638; p< 0.0001; RM: F(13,429) = 12.839; p< 0.0001),
with errors decreasing across days, demonstrating learning.
Figures 1A–C show mean errors scores (+SE) for each block
for WMC, WMI, and RM, respectively, for each treatment
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FIGURE 1 | Mean error scores (+SE) on the water-radial arm maze.
(A) Working Memory Correct (WMC) error scores, (B) Working Memory
Incorrect (WMI) error scores, and (C) Reference Memory (RM) error scores
across all days of regular testing in 4–5 day blocks. (D) WMI error scores on
Block 2. (E) WMI error scores on Trials 1–4 on Block 2. (F) WMI error
scores on Trial 4 on Block 2. *p < 0.05.
group. For WMI, there was a significant omnibus ANOVA
main effect of Treatment for Block 2 [F(3,33) = 5.221; p <
0.005 (Figure 1D)]. Progesterone impaired performance as
evidenced by the Ovx+Prog group committing more errors
than the Ovx+Vehicle [t(17) = 2.727; p < 0.05] and Ovx+Bic
[t(16) = 3.093; p < 0.01] groups. The addition of bicuculline
reversed progesterone-induced working memory impairment
as evidenced by the Ovx+Prog+Bic group committing fewer
errors than the Ovx+Prog group [t(16) = 2.435; p < 0.05] and
performing similarly to the Ovx+Vehicle group. Within this
block, there was also a significant Trial x Treatment interaction
for WMI errors [F(9,99) = 2.621; p < 0.01 (Figure 1E)]. At the
highest working memory load (Trial 4) in Block 2, there was a
main effect of Treatment [F(3,33) = 3.393; p < 0.05 (Figure 1F)],
with the Ovx+Prog group committing more WMI errors
than all other treatment groups [Ovx+Prog vs. Ovx+Vehicle:
t(17) = 2.053; p < 0.05; Ovx+Prog vs. Ovx+Prog+Bic: t(16)
= 2.349; p < 0.05; Ovx+Prog vs. Ovx+Bic: t(16) = 2.094;
p = 0.05 (Figure 1F)]. These working memory load effects
support a progesterone-induced working memory impairment
that is reversed by the addition of bicuculline. There were
no significant Treatment effects or interactions for WMI
errors during Blocks 1 or 3, and no significant Treatment
effects or interactions for WMC or RM errors during any
block.
After regular testing, a 6 h delay was administered between
Trials 2 and 3. For WMC errors, we compared baseline
performance on Trial 3 on Day 14 (the last day of regular
testing) to Trial 3 performance immediately after the delay
on Day 15, within each group. There was no statistically
significant difference between groups on Trial 3 Day 14 baseline
performance [F(3,33) = 0.685; p = 0.568 (Figure 2)]. The
Ovx+Prog group was the only group to significantly increase
errors after the delay [Ovx+Prog, baseline vs. delay: t(8) =
3.162; p< 0.05], demonstrating a susceptibility to delay-induced
working memory impairments in progesterone-treated animals
(Figure 2). The progesterone-induced impairment was obviated
with the addition of bicuculline, as the Ovx+Prog+Bic group did
not show a delay-induced impairment [Ovx+Prog+Bic, baseline
vs. delay: t(8) = 0.634; p = 0.54]. No group displayed a delay-
induced increase in WMI or RM errors.
Visible Platform Maze
For the visible platform task, there was a main effect of
Trial [F(5,165) = 16.642; p < 0.0001 (Figure 3)], with Latency
decreasing across all trials, demonstrating task learning. The
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FIGURE 2 | Mean WMC error scores (+SE) on the water radial-arm maze for baseline (last day of regular testing Trial 3) vs. delay (Trial 3 immediately
following a 6 h delay). *p < 0.05.
omnibus ANOVA Treatment effect was not significant for
Latency to the visible platform. By the fourth trial, all treatment
groups found the visible platform within 9 s, confirming
visual and motor competence to perform a water-escape swim
task.
Vaginal Smears
Twelve and 13 days after Ovx, vaginal smears were taken and
classified as proestrus, estrous, metestrus or diestrous phases,
per prior protocols (Goldman et al., 2007; Acosta et al., 2009).
As expected, regardless of treatment, all rats showed leukocytic
smears, indicative of a lack of vaginal stimulation (Braden et al.,
2010).
Uterine Weights
The omnibus ANOVA Treatment effect was not significant
for uterine weight indicating that neither the progesterone
nor bicuculline impacted this variable, replicating a lack of
progesterone effect on uterus shown previously (Braden et al.,
2010; Table 1).
Discussion
Natural progesterone (in its micronized form) is a clinically
used component of both contraceptives and HT, and has been
discussed to be a promising new candidate to replace the
synthetic progestin, MPA, as the progestogen component in HT
(Sturdee et al., 2011; The Writing Group for the PEPI Trial,
1995; Langer, 1999). The results herein add to a growing body
of literature implicating both MPA and natural progesterone as
detrimental to cognition in the middle-aged to aged surgically
menopausal rat (Bimonte-Nelson et al., 2004b, 2006; Braden
et al., 2010, 2011; Lowry et al., 2010; but see Chisholm and
Juraska, 2012). Here, using middle-aged surgically menopausal
rats, we found that progesterone treatment transiently impaired
working memory performance, and also resulted in a delay-
induced impairment on the WRAM. Specifically, the present
study replicates WRAM findings from Bimonte-Nelson et al.
(2004b) whereby, after an initial learning block, progesterone-
treated aged surgically menopausal rats committed more WMI
errors across all trials and at the most demanding working
FIGURE 3 | Mean latency scores in seconds (+SE) on the visible
platform maze.
memory load, as compared to vehicle-treated rats. Both
progesterone-induced impairments in the current study were
obviated by the addition of bicuculline. In addition, we found
that progesterone, with or without bicuculline, had no impact on
uterine weights or vaginal smears, supporting the lack of uterine
stimulation expected with progesterone (Kirkland et al., 1992;
Braden et al., 2010).
Although this is the third report of progesterone-induced
cognitive impairments in middle-aged or aged Ovx rats
(Bimonte-Nelson et al., 2004b; Braden et al., 2010), it is noted
that overall the literature on progesterone effects on cognition
in young Ovx rodents is mixed. Some studies show beneficial
effects, mostly related to non-spatial memory (Frye et al., 2007;
Frye and Walf, 2008; Harburger et al., 2008; Orr et al., 2009),
while others show spatial memory impairments (Sun et al., 2010).
When combined with 17β-estradiol, progesterone can abolish
17β-estradiol-induced memory improvements (Bimonte-Nelson
et al., 2006; Harburger et al., 2007; Lowry et al., 2010; but
see Gibbs, 2000; Markham et al., 2002) and can attenuate
17β-estradiol’s neurotrophic/neuroprotective effects in vivo
(Bimonte-Nelson et al., 2004a; Rosario et al., 2006; Carroll et al.,
2008), and in cell culture (Nilsen and Brinton, 2002a; Aguirre
and Baudry, 2009). Further, administration of the progesterone
metabolite, allopregnanolone, can impair cognition in young rats
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TABLE 1 | Mean uterine weights in g (±SE).
Ovx+Vehicle Ovx+Prog Ovx+Bic Ovx+Prog+Bic
Uterine Weight (g) 0.169 ± 0.04 0.205 ± 0.02 0.194 ± 0.03 0.189 ± 0.01
(Frye and Sturgis, 1995; Ladurelle et al., 2000; Johansson et al.,
2002; Rabinowitz et al., 2014).
The goal of the current study was to assess the mechanism
by which progesterone impairs memory, in the middle-aged
surgically menopausal rat model, building on previous research
that progesterone’s metabolites interact with the GABAergic
system, acting as positive allosteric modulators (Paul and
Purdy, 1992; Lan and Gee, 1994). Thus, we hypothesized that
progesterone-mediated cognitive impairments may be initiated
via pro-GABAergic actions, and that concomitant treatment
with the GABAA receptor antagonist, bicuculline, would block
these impairments. In support of this hypothesis, we found
that both the progesterone-induced impairment on working
memory performance and delay retention, as evaluated by the
WRAM, were reversed by the addition of bicuculline. Our
findings are in line with a previous report of treatment with
the GABAA receptor antagonist, picrotoxin, attenuating the
impairing effect of progesterone on an emotional learning task
(Farr et al., 1995). The role of the GABAergic system in
memory formation and retrieval has in part been delineated
through administration of agonists and antagonists via systemic
injections and local brain infusions (Izquierdo et al., 1993). An
increase in GABA-mediated inhibition may impair memory on
several levels. Briefly, findings show that GABAergic agonists
inhibit the induction phase of LTP, and if administered post-
training, can result in retrograde amnesia (Izquierdo et al.,
1993).
The transient nature of the progesterone-impairing effect on
learning is interesting, and may involve homeostatic plasticity
changes via glutamatergic neurons. In addition to having pro-
GABAergic actions, progesterone suppresses glutamate-induced
excitation (Smith et al., 1987), protects against glutamate-
induced toxicity (Nilsen and Brinton, 2002b), and decreases
NMDA binding (Cyr et al., 2000). While to our knowledge
the time course of the interplay between these opposing effects
has not been extensively investigated for progesterone, this has
been investigated for another ovarian hormone, 17β-estradiol.
17β-estradiol has been shown to alter the interplay between
GABAergic and glutamatergic systems in a manner opposite
to that of progesterone. 17β-estradiol suppresses GABAergic
transmission while having pro-glutamatergic actions, which
is a possible mechanism for dendritic spine formation and
memory enhancement (Woolley et al., 1997; Bimonte and
Denenberg, 1999; Rudick and Woolley, 2001; Segal and Murphy,
2001). After several days, 17β-estradiol-induced changes in
GABAergic and glutamatergic systems ultimately result in a
balance of excitation and inhibition, but possibly increase
the long-term dynamic range of the system (Rudick and
Woolley, 2001). Intuitively, the opposite pattern of effects
by progesterone on the interplay between GABAergic and
glutamatergic systems may decrease the dynamic range of the
system. Indeed, progesterone has been shown to attenuate
17β-estradiol-mediated dendritic spine formation (Woolley and
McEwen, 1993; Segal and Murphy, 2001; but see Gould et al.,
1990). The behavioral outcome of reduced spine formation and
a long-term ‘‘decreased dynamic range’’ of memory systems may
be slowed learning, such as the transient effect of progesterone
administration observed in the present study. This is in contrast
to amnestic effects that persist through the entirety of maze
testing, such as those observed with lesions to memory forming
brain structures. Future research is necessary to delineate the
time course of progesterone effects on the interplay between
GABAergic and glutamatergic systems and how that might affect
learning.
We have previously shown that a longer course (2 months)
of progesterone or MPA treatment in aged Ovx rats
decreased protein levels of CA1/2 hippocampal GAD
(Braden et al., 2010). Wallis and Luttge (1980) found a
similar effect of progesterone decreasing hippocampal
GAD activity in young Ovx rats and others have found
progesterone to alter mRNA levels of GAD (Weiland,
1992) and subunits of the GABAA receptor (Weiland and
Orchinik, 1995; Pazol et al., 2009) in the CA1. Similar
changes in GAD and/or GABAA receptor subunit expression
may also be a mechanism of short-term progesterone-
induced learning and memory impairments, and bicuculline
reversal, observed herein. While this study implicates the
GABAergic system in facilitating progesterone-induced
cognitive impairments in the middle-aged Ovx rat, future
investigations are warranted to further elucidate the
neurochemical changes that accompany these cognitive
impairments. This work is integral to the mechanistic
understanding of progestogen-induced cognitive impairments
in order to determine safe progestogen use, with respect to
cognition, for combination birth control and HT p rescribed to
women.
In conclusion, the current report indicates that: (1) short-term
progesterone treatment transiently impairs working memory
performance and results in a delay-induced impairment on
the WRAM; and (2) these progesterone impairments are
reversed by concomitant treatment with the GABAA receptor
antagonist, bicuculline. These findings support the hypothesis
that progesterone-induced memory impairments in the middle-
aged Ovx rat are in part mediated via pro-GABAergic actions.
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